The NIRSE-GAL study, conducted in Galicia, Spain, is the first real-world, population-based investigation of a universal RSV immunization program spanning two consecutive seasons
ADQUEY’s approval opens the door to a new alternative for millions of Americans struggling with atopic dermatitis
Alphyn is developing Zabalafin Hydrogel as the first therapy to simultaneously tackle the interconnected drivers of AD
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
_Rupak_Singla_256_384.jpg)
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Subscribe To Our Newsletter & Stay Updated
